RALEIGH, N.C. — The Food and Drug Administration gave approval Wednesday to Salix Pharmaceuticals to begin marking of a bowel-cleansing drug.

The drug, MoviPrep, is for use by patients preparing to have a colonoscopy.

Salix licensed the drug from Norgine BV, a European specialty pharmaceutical firm.

Salix: www.salix.com